tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Edwards Lifesciences price target lowered to $87 from $90 at Baird
PremiumThe FlyEdwards Lifesciences price target lowered to $87 from $90 at Baird
22d ago
Edwards Lifesciences: Capitalizing on TAVR Tailwinds, New Structural Heart Catalysts, and Attractive Valuation Upside
Premium
Ratings
Edwards Lifesciences: Capitalizing on TAVR Tailwinds, New Structural Heart Catalysts, and Attractive Valuation Upside
22d ago
Edwards Lifesciences: Sustained TAVR Momentum, Margin Upside, and New LAAC Growth Support Buy Rating
Premium
Ratings
Edwards Lifesciences: Sustained TAVR Momentum, Margin Upside, and New LAAC Growth Support Buy Rating
22d ago
Closing Bell Movers: Robinhood slips 8% after revenue miss
PremiumThe FlyClosing Bell Movers: Robinhood slips 8% after revenue miss
22d ago
Edwards Lifesciences reports Q4 adjusted EPS 58c, consensus 62c
Premium
The Fly
Edwards Lifesciences reports Q4 adjusted EPS 58c, consensus 62c
22d ago
Edwards Lifesciences sees Q1 adjusted EPS 70c-76c, consensus 69c
Premium
The Fly
Edwards Lifesciences sees Q1 adjusted EPS 70c-76c, consensus 69c
22d ago
Is EW a Buy, Before Earnings?
PremiumPre-EarningsIs EW a Buy, Before Earnings?
25d ago
Edwards Lifesciences price target lowered to $94 from $95 at UBS
Premium
The Fly
Edwards Lifesciences price target lowered to $94 from $95 at UBS
29d ago
Edwards Lifesciences: Buy Rating Backed by Favorable TAVR Reimbursement Outlook and Asymptomatic Coverage Upside
Premium
Ratings
Edwards Lifesciences: Buy Rating Backed by Favorable TAVR Reimbursement Outlook and Asymptomatic Coverage Upside
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100